179 related articles for article (PubMed ID: 23539074)
1. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
Cho HY; Kim K; Jeon YT; Kim YB; No JH
Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
[TBL] [Abstract][Full Text] [Related]
2. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
Chen JM; Gao HY; Wang Q; Li Q
Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
[TBL] [Abstract][Full Text] [Related]
5. Age-stratified analysis of tumor markers and tumor characteristics in adolescents and young women with mature cystic teratoma.
Yesilyurt H; Seckin B; Aktulay A; Ozyer S
J Chin Med Assoc; 2018 Jun; 81(6):499-504. PubMed ID: 28826726
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
[TBL] [Abstract][Full Text] [Related]
7. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
[TBL] [Abstract][Full Text] [Related]
8. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
[TBL] [Abstract][Full Text] [Related]
9. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
[TBL] [Abstract][Full Text] [Related]
11. Elevated CA 19-9 levels in mature cystic teratoma of the ovary.
Kyung MS; Choi JS; Hong SH; Kim HS
Int J Biol Markers; 2009; 24(1):52-6. PubMed ID: 19404923
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers in mature cystic teratomas of the ovary.
Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
[TBL] [Abstract][Full Text] [Related]
13. CA19-9 may have clinical significance in mature cystic teratomas of the ovary.
Dede M; Gungor S; Yenen MC; Alanbay I; Duru NK; Haşimi A
Int J Gynecol Cancer; 2006; 16(1):189-93. PubMed ID: 16445632
[TBL] [Abstract][Full Text] [Related]
14. Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report.
Sampaio J; Sarmento-Gonçalves I; Barros JM; Felix J; Tiago-Silva P
Rev Bras Ginecol Obstet; 2016 Jul; 38(7):365-7. PubMed ID: 27434195
[TBL] [Abstract][Full Text] [Related]
15. Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.
Nanki Y; Chiyoda T; Kataoka F; Nomura H; Nakadaira N; Iwasa N; Hashimoto S; Arima H; Susumu N; Aoki D
J Obstet Gynaecol Res; 2017 Apr; 43(4):744-748. PubMed ID: 28370831
[TBL] [Abstract][Full Text] [Related]
16. Mature cystic teratomas: relationship between histopathological contents and clinical features.
Cakmak B; Nacar M; Ozsoy Z; Aliyev N; Koseoglu D
Niger J Clin Pract; 2015; 18(2):236-9. PubMed ID: 25665999
[TBL] [Abstract][Full Text] [Related]
17. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.
Cho HY; Kyung MS
Med Sci Monit; 2014 Jul; 20():1334-9. PubMed ID: 25073801
[TBL] [Abstract][Full Text] [Related]
18. Can malignant transformation in mature cystic teratoma be preoperatively predicted?
Futagami M; Yokoyama Y; Mizukami H; Shigeto T; Mizunuma H
Eur J Gynaecol Oncol; 2012; 33(6):662-5. PubMed ID: 23327068
[TBL] [Abstract][Full Text] [Related]
19. Role of elevated cancer antigen 19-9 in women with mature cystic teratoma.
Frimer M; Seagle BL; Chudnoff S; Goldberg GL; Shahabi S
Reprod Sci; 2014 Oct; 21(10):1307-11. PubMed ID: 24577158
[TBL] [Abstract][Full Text] [Related]
20. Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
Zhang W; Wang L; Xin Z
Medicine (Baltimore); 2018 Apr; 97(16):e0358. PubMed ID: 29668586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
